Skip to content
S4870Senate2021-2022 SessionSame asA3040

Let Pharmacists Give Injections

Official title

“Relates to the definition of the practice of pharmacy”

Sponsor Neil D. BreslinSD-44+1 co-sponsorAffects Education
Status
Signed by Governor
Impact
7/10
Significant
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill allows pharmacists to administer injectable medications for mental health and substance use disorders under specific regulations.

Why it matters

  1. Increases access to critical mental health and substance use treatments. by allowing pharmacists—who are often more accessible than doctors—to administer long-acting injectable medications, potentially reducing missed doses and improving continuity of care for vulnerable populations.

  2. Imposes strict regulatory and training requirements. to ensure patient safety, including accredited training for pharmacists on injection techniques, adverse reaction management, patient consent, and emergency procedures, which may reassure patients and providers about the quality of care.

  3. Enhances coordination between pharmacists and prescribers. by requiring pharmacists to notify prescribers after administering injections and to report any adverse reactions, supporting better monitoring and integrated care for patients.

  4. Addresses privacy and informed consent. by mandating private areas for injections in pharmacies and ensuring that patients (or their legal representatives) are fully informed and consenting, thus protecting patient rights and dignity.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Let Pharmacists Give Injections

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 44

Chair, Insurance

History

  1. Approval memo.87
  2. Signed chap.802
  3. Delivered to governor
  4. Returned to senate
  5. Passed assembly
  6. Ordered to third reading rules cal.442
  7. Substituted for A3040B
  8. Referred to higher education
  9. Delivered to assembly
  10. Passed senateVote 59–4
  11. Amended on third reading 4870b
  12. Advanced to third reading
Show 6 earlier actions
  1. 2nd report cal.
  2. 1st report cal.1238
  3. Referred to higher education
  4. Print number 4870a
  5. Amend and recommit to higher education
  6. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3040Assembly

Let Pharmacists Give Mental Health Shots

Assembly Floor Calendar · Sponsor John T. McDonald III

Impact 6 · Moderate0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

4870--B Cal. No. 1238

2021-2022 Regular Sessions

IN SENATE

February 17, 2021

Introduced by Sens. BRESLIN, ADDABBO -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- recommitted to the Committee on Higher Education in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading

AN ACT to amend the education law, in relation to the definition of the practice of pharmacy

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 22 of section 6802 of the education law, as amended by chapter 555 of the laws of 2021, is amended to read as follows:

22. "Administer", for the purpose of section sixty-eight hundred one of this article, means:

a. (1) the direct application of an immunizing agent to adults, whether by injection, ingestion, inhalation or any other means, pursuant to a patient specific order or non-patient specific regimen prescribed or ordered by a physician or certified nurse practitioner, for: immunizations to prevent influenza, pneumococcal, acute herpes zoster, hepatitis A, hepatitis B, human papillomavirus, measles, mumps, rubella, varicella, COVID-19, meningococcal, tetanus, diphtheria or pertussis disease and medications required for emergency treatment of anaphylaxis; and other immunizations recommended by the advisory committee on immunization practices of the centers for disease control and prevention for patients eighteen years of age or older if the commissioner of health in consultation with the commissioner determines that an immunization: (i)(A) may be safely administered by a licensed pharmacist within their lawful scope of practice; and (B) is needed to prevent the transmission

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03519-09-2

of a reportable communicable disease that is prevalent in New York state; or (ii) is a recommended immunization for such patients who: (A) meet age requirements, (B) lack documentation of such immunization, (C) lack evidence of past infection, or (D) have an additional risk factor or another indication as recommended by the advisory committee on immunization practices of the centers for disease control and prevention. If the commissioner of health determines that there is an outbreak of disease, or that there is the imminent threat of an outbreak of disease, then the commissioner of health may issue a non-patient specific regimen applicable statewide.

[b.] (2) the direct application of an immunizing agent to children between the ages of two and eighteen years of age, whether by injection, ingestion, inhalation or any other means, pursuant to a patient specific order or non-patient specific regimen prescribed or ordered by a physician or certified nurse practitioner, for immunization to prevent influenza and medications required for emergency treatment of anaphylaxis resulting from such immunization. If the commissioner of health determines that there is an outbreak of influenza, or that there is the imminent threat of an outbreak of influenza, then the commissioner of health may issue a non-patient specific regimen applicable statewide.

b. The injection of medications into the deltoid muscle for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within the scope of their practice in this state and in accordance with regulations promulgated by the commissioner and the department of health in consultation with any other state agencies as necessary, but not be limited to, providing that:

(1) Such administration is conducted pursuant to a valid prescription or order that authorizes a pharmacist to administer medications for the treatment of mental health and substance use disorder and the pharmacist notifies the licensed prescriber that the administration is complete. Administration in a pharmacy may not commence until after the patient has received the initial injection and is considered eligible for maintenance treatment by the licensed prescriber.

(2) Such prescription may be subject to reassessment at appropriate intervals, as determined by the licensed prescriber.

(3) Such activity is conducted in accordance with regulations, promulgated or adopted by the commissioner and the department of health, in consultation with any other state agencies, as necessary, which shall include requirements for the following:

(i) Training accredited by the accreditation council for pharmacy education, that may include educational experiences obtained through pharmacy school curricula, or a similar health authority or professional body appropriate for the medications being administered and their respective patient populations. Such training must be satisfactory to the commissioner and the department of health, in consultation with the board of pharmacy and any other state agencies, as necessary, which shall include, but not be limited to learning modules on techniques for administration by injections, indications, precautions, and contraindications in the use of agent or agents; record keeping and information; and handling emergencies, including anaphylaxis, needle-sticks and cardiopulmonary resuscitation.

(ii) Maintaining continued competency regarding the populations served and medications administered.

(iii) Pre-administration patient consent and education regarding common side effects, drug interactions, injection site reactions and other information routinely provided to patients upon dispensing. If a patient is unable to provide consent, the pharmacist must obtain consent from a person legally responsible when the recipient is incapable of consenting.

(iv) When administering an injection in a pharmacy, the pharmacist shall provide an area for the injection that provides for the patient's privacy.

(v) Record keeping and reporting of such administration by electronic transmission or facsimile to the patient's licensed prescriber, and, to the extent practicable, make himself or herself available to discuss the outcome of such injection, including any adverse reactions, with the licensed prescriber acting within their scope of practice.

§ 2. Section 6801 of the education law is amended by adding a new subdivision 8 to read as follows:

8. A licensed pharmacist within their lawful scope of practice may administer injectable medications into the deltoid muscle, pursuant to section six thousand eight hundred two of this article, for the treatment of mental health and substance use disorder, as prescribed or ordered by a licensed prescriber, acting within their scope of practice in this state and in accordance with regulations, including but not limited to regulations promulgated by the commissioner in consultation with any other state agencies, as necessary.

§ 3. This act shall take effect one year after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed by the commissioner of education on or before such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the education law, in relation to the definition of the practice of pharmacy

Purpose

This bill allows pharmacists to administer injectable medications for substance abuse and mental health.

Summary of provisions

Section 1 amends Education Law Section 6802, subdivision 22 as added by chapter 46 of the laws of 2015 to include pharmacist administered injections for mental health and substance use disorders within the definition of administer.

Section 2 amends Education Law Section 6802, subdivision 22 as added by chapter 563 of the laws of 2008 to include pharmacist administered injections for mental health and substance use disorders within the definition of administer.

Section 3 amends Education Law Section 6801 to create a new subdivision 6 to allow a licensed pharmacist to administer injectable medications for the treatment of mental health and substance use disorders.

Section 4 lists the effective date

Justification

New York is one of 11 states that do not allow pharmacist medication administrative authority for non-vaccine items and one of 14 states that do not allow pharmacists the administrative authority to administer Long-Acting Injectable Antipsychotics.

There is a public health need in the US for increased access to behav- ioral health services-including Long Acting Injectable's (LAI's) that are either used for mental health or substance abuse disorders. The challenge with the oral forms of these medications is non-adherence, which is very prevalent. For example, half of patients diagnosed with schizophrenia do not take their medications as prescribed and re-admis- sion rates are five times higher in patients who are non-adherent than those who are adherent. This high rate of non-adherence can be linked to many reasons including the side effects of the medications, diversion and other factors that can contribute to clinical relapses and hospital- izations which can cause significant distress for the patient and high costs to the health care system. More importantly, treatment goals are not being met which is of benefit to the patient and society as a whole.

Due to the high accessibility of community pharmacies which are much closer to patients homes and have more extensive hours of operations than a clinic setting, pharmacists are well suited to administer LAIs in the community setting. Additionally, pharmacies are able to provide on-demand or appointment based delivery - as has been implemented for vaccine administration, and they are well equipped to maintain a large medication inventory, something medical offices are not well-suited for. Moreover, the ability to allow pharmacists to administer LAI's in the community setting will also help reduce the stigma of patients who need to go to a specific-type of clinic for their disease which at times is not only a challenge with transportation but also with how they feel they will be perceived.

Finally, in the community pharmacy setting, pharmacies are able to include policies and procedures for communicating care delivery back to the patient's health care provider and other coordination services which is critical information that a provider cannot always access easily.

This bill will improve patient access and adherence while reducing stig- ma at a time when a growing number of individuals are living in our community struggling with mental health concerns and/or a substance abuse disorder.

Legislative history

2017-2018 A.8661

2019-2020 S.4848- Passed Senate; Died in Assembly; Referred to Higher Education

Fiscal implications

None

Effective date

This act shall take effect on the one-hundredth and eightieth day after it shall have become law subject to additional provisions.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.